Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Baltar

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
International Journal of Obesity (2005)|June 8, 2017
Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?A B Crujeiras, D Gomez-Arbelaez, M A Zulet, et al.
American Journal of Nephrology|May 22, 2013
Mycophenolate as maintenance therapy for lupus nephritis with impaired renal functionF Rivera, M L Illescas, E López-Rubio, et al.
American Journal of Nephrology|April 21, 2012
Mycophenolate as induction therapy in lupus nephritis with renal function impairmentF Rivera, X Fulladosa, R Poveda, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
International Journal of Obesity (2005)|June 8, 2017
Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?A B Crujeiras, D Gomez-Arbelaez, M A Zulet, et al.
American Journal of Nephrology|May 22, 2013
Mycophenolate as maintenance therapy for lupus nephritis with impaired renal functionF Rivera, M L Illescas, E López-Rubio, et al.
American Journal of Nephrology|April 21, 2012
Mycophenolate as induction therapy in lupus nephritis with renal function impairmentF Rivera, X Fulladosa, R Poveda, et al.
Pageof 5